[Research progress on the diagnostic performance and predictive accuracy of different prognostic scores as non-invasive liver fibrosis models for primary biliary cholangitis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiFeng J +5 more
europepmc +1 more source
[Role of metabolic reprogramming-mediated hepatic stellate cell activation in the pathogenesis of hepatic fibrosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiXiao Y, Wu ZN, Lu J, Wang YD.
europepmc +1 more source
[Meta-analysis of the efficacy of the Fuzheng Huayu formula in the treatment of hepatitis B-associated liver fibrosis or cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiFan Y +5 more
europepmc +1 more source
[Challenges and optimization strategies for clinical research and the development of new drugs for liver fibrosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiCai XB, Qu Y, Lu LG.
europepmc +1 more source
[Analysis of core functional components in Yinchenhao Decoction and their pathways for treating liver fibrosis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoChen X +8 more
europepmc +1 more source
[Compound <i>Centella asiatica</i> formula alleviates <i>Schistosoma japonicum</i>-induced liver fibrosis in mice by inhibiting the inflammation-fibrosis cascade via regulating the TLR4/MyD88 pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoGuan L +11 more
europepmc +1 more source
[Inhibiting Yes-associated protein alleviates CCl4 liver fibrosis in mice by reducing epithelial mesenchymal transition]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoZhao W +6 more
europepmc +1 more source
[Characteristics of liver volume and pathological changes with different stages of liver fibrosis in chronic liver disease]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhu TT +7 more
europepmc +1 more source
[Long-term therapeutic outcomes of antiviral treatment in patients with chronic hepatitis B infection with normal alanine aminotransferase, mild liver inflammation, and fibrosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiShi YC, Tan YW.
europepmc +1 more source